Objective informational resource
for industry professionals

Вас может заинтересовать:

Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
WEB only
Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
On June 26, 2023, the Japanese Pharmaceutical Company Shionogi & Co., Ltd and the Medicines Patent Pool (MPP), a United Nations-backed international public health organization, have announced the signature of…
Sartorius and Repligen launch an intensification system for advanced processing
WEB only
Sartorius and Repligen launch an intensification system for advanced processing
The life science group Sartorius and Repligen Corporation today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified…
X

error

Подобається наш журнал! Розкажи про нас

RSS
Follow by Email
Facebook
Twitter
LinkedIn
LinkedIn
Share
Для копіювання будь-ласка увійдіть в свій аккаунт